← back to search

Zhengkui Sun

Nanchang University · CN
🔎 Find collaborators in Oncology · Pulmonary and Respiratory Medicine →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research focused on Breast cancer and Triple-negative breast cancer, with related work in Metastatic breast cancer, GPER, Mendelian randomization. Notable publications include 'Sacituzumab tirumotecan (SKB264/MK-2870) in patients (pts) with previously treated locally recurrent or metastatic triple-negative breast cancer (TNBC): Results from the phase III...', 'Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial', and 'Microenvironmental G protein‐coupled estrogen receptor‐mediated glutamine metabolic coupling between cancer‐associated fibroblasts and triple‐negative breast cancer cells governs...'.
h-index
citations
133
works
10
NIH funding
primary concept
email

Recent publications

Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial
Nature Medicine 2025cited by 39position: middledoi
Safety and quality of life of CDK4/6 inhibitors therapy for hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: a multicenter cross-sectional survey in China
BMC Cancer 2025cited by 1position: middledoi
Sacituzumab tirumotecan (SKB264/MK-2870) in patients (pts) with previously treated locally recurrent or metastatic triple-negative breast cancer (TNBC): Results from the phase III OptiTROP-Breast01 study.
Journal of Clinical Oncology 2024cited by 43position: middledoi
Microenvironmental G protein‐coupled estrogen receptor‐mediated glutamine metabolic coupling between cancer‐associated fibroblasts and triple‐negative breast cancer cells governs tumour progression
Clinical and Translational Medicine 2024cited by 16position: middledoi
Case report: Report of a rare encounter: metastasis of renal cell carcinoma to the thyroid
Frontiers in Oncology 2024cited by 6position: middledoi
Research trends, hotspots and future directions of tertiary lymphoid structures in cancer: a comprehensive informatics analysis and visualization study
Discover Oncology 2024cited by 5position: lastdoi
Safety and patient-reported outcomes in patients with hormone receptor-positive, HER2-negative advanced breast cancer treated with CDK4/6 inhibitors in China: A cross-sectional study.
Journal of Clinical Oncology 2024cited by 1position: middledoi
Visualization of breast cancer-related protein synthesis from the perspective of bibliometric analysis
European journal of medical research 2023cited by 9position: middledoi
Causal relationship between dietary factors and breast cancer risk: A Mendelian randomization study
Heliyon 2023cited by 9position: middledoi
Breast mass as the first sign of metastasis from rectal carcinoma: a case report and review of the literature
Frontiers in Oncology 2023cited by 4position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jiawei Xu · Fudan University5 papers (2023–2024)Siyi Xu · Nanchang University4 papers (2023–2024)Chengdong Yu · Nanchang University4 papers (2023–2024)Zhongsheng Tong · Tianjin Medical University Cancer Institute and Hospital4 papers (2024–2025)Tenghua Yu · Nanchang University3 papers (2023–2024)Yiding Chen · Ministry of Education of the People's Republic of China2 papers (2024–2025)Jiong Wu · Shanghai Medical College of Fudan University2 papers (2024–2025) · 2 papers (2024–2025)Lei Tang · Nanchang University2 papers (2024–2024)Xiaofang Zhang · Nanchang University2 papers (2023–2024)Xiaoqiang Zeng · Nanchang University2 papers (2023–2024)Xi Yan · Henan Normal University2 papers (2024–2025) · 2 papers (2024–2025)Yuee Teng · China Pharmaceutical University2 papers (2024–2025)Xianjun Tang · Chongqing University2 papers (2024–2025) · 2 papers (2024–2025)Quchang Ouyang · Central South University2 papers (2024–2024)Mu Tang · Nanchang University2 papers (2024–2025) · 2 papers (2024–2025)Man Li · Zhejiang Chinese Medical University2 papers (2024–2025)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Oncology · Pulmonary and Respiratory Medicine →